Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response

In view of the fact that controlled prospective studies on the benefits of dose escalation of the selective serotonin re‐uptake inhibitor (SSRI) paroxetine are lacking, we conducted a double‐blind, randomized, parallel‐group multicentre study designed to compare the possible benefits of dose escalat...

Ausführliche Beschreibung